MDXG - Largest U.S. payor to cover MiMedx's EpiFix for diabetic foot ulcers
MiMedx Group (MDXG) announces that the largest U.S. commercial payor will cover its EpiFix tissue product for the treatment of diabetic foot ulcers effective December 1.Beleaguered longs are hoping the news lifts the stock considering its 20% drop this year.
For further details see:
Largest U.S. payor to cover MiMedx's EpiFix for diabetic foot ulcers